Two Sigma Securities’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,600
Closed -$277K 3405
2024
Q2
$277K Sell
2,600
-12,200
-82% -$1.22M ﹤0.01% 2062
2024
Q1
$1.43M Buy
14,800
+7,200
+95% +$738K 0.01% 932
2023
Q4
$767K Buy
7,600
+100
+1% +$9.65K 0.01% 1220
2023
Q3
$764K Buy
7,500
+100
+1% +$10.2K 0.01% 1225
2023
Q2
$747K Buy
+7,400
New +$740K 0.01% 1166
2022
Q2
Sell
-4,000
Closed -$351K 2665
2022
Q1
$351K Buy
+4,000
New +$346K 0.01% 1274
2021
Q1
Sell
-6,600
Closed -$623K 1479
2020
Q4
$623K Sell
6,600
-2,500
-27% -$218K 0.01% 591
2020
Q3
$791K Buy
9,100
+600
+7% +$52K 0.02% 421
2020
Q2
$742K Buy
8,500
+3,600
+73% +$311K 0.02% 485
2020
Q1
$404K Sell
4,900
-27,500
-85% -$2.45M 0.01% 704
2019
Q4
$3.07M Sell
32,400
-3,400
-9% -$305K 0.02% 568
2019
Q3
$3.11M Sell
35,800
-8,700
-20% -$781K 0.03% 432
2019
Q2
$4.06M Buy
+44,500
New +$3.77M 0.04% 276
2018
Q4
Sell
-55,242
Closed -$4.26M 2619
2018
Q3
$4.26M Sell
55,242
-45,533
-45% -$3.37M 0.03% 422
2018
Q2
$6.82M Buy
100,775
+58,255
+137% +$4.02M 0.03% 388
2018
Q1
$3.08M Buy
42,520
+36,159
+568% +$2.75M 0.02% 668
2017
Q4
$479K Buy
+6,361
New +$480K 0.01% 726

Other funds holding NVS

Two Sigma Securities's NVS Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Novartis (NVS) in Q2 2026: 3,246 shares worth $509K. The stake represents 0.04% of the portfolio and ranks #573 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in NVS as recently as Q2 2025.

Two Sigma Securities first reported a position in NVS in Q1 2017 and has held it in 18 quarters since. The position peaked at $10.7M in Q1 2018. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Two Sigma Securities held 3,246 shares of Novartis worth $509K as of Q2 2026.
  • Novartis was a new Two Sigma Securities position in Q2 2026.
  • Novartis made up 0.04% of Two Sigma Securities's portfolio in Q2 2026, its #573 holding.
  • Two Sigma Securities first reported a position in Novartis in Q1 2017 and has held it in 18 quarters since.
  • Two Sigma Securities's Novartis position peaked at $10.7M in Q1 2018.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.